Managing Polypharmacy in Individuals with Anxiety and/or Depression

• By: Frank Longo, RPh Precision LTC Pharmacy
• September 29th, 2025
• adverse drug interactions, anxiety medication, cognitive decline, depression medication, Fall 2025 Issue, long-term care, medication management, pharmacist role, polypharmacy
• 978    0

Many people who take medications to treat anxiety and/or depression also take drugs to manage additional chronic conditions. So-called polypharmacy – which is generally defined as the concurrent use of five or more medications – can lead to a host of problems, including increased risk of...

Integrated Psychiatry for Individuals with Developmental Disabilities

• By: Shawn P. Quigley, PhD, BCBA-D Danielle Block MBA, BSN, RN Frank L. Bird MEd, BCBA, LABA Melmark
• October 1st, 2019
• behavior analysis, developmental disabilities, integrated care, interdisciplinary teams, polypharmacy, psychotropic medication, residential treatment
• 1308    0

Use of psychotropic drugs for individuals with developmental disabilities is common practice. For example, Jobski, Hofer, Hoffman, and Bachmann (2016) documented an overall median use of psychotropic drugs in 45.7% of individuals with autism spectrum disorder (ASD). Wink et al., (2018) documented...